6,826 Shares in Cigna Group $CI Acquired by Capital City Trust Co. FL

Key Points

• Capital City Trust Co. FL acquired 6,826 shares of Cigna Group, valuing the investment at approximately $2,257,000 in the second quarter of the year.
• Insider Nicole S. Jones sold 28,526 shares of Cigna Group, representing a 52.66% decrease in her holdings, totaling around $8.56 million from the sale.
• Cigna Group reported $7.20 earnings per share (EPS) in its latest quarterly earnings, surpassing the consensus estimate by $0.05, with revenues up 11.0% year-over-year.

Capital City Trust Co. FL acquired a new position in shares of Cigna Group (NYSE:CI - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,826 shares of the health services provider's stock, valued at approximately $2,257,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Flaharty Asset Management LLC acquired a new stake in Cigna Group during the 1st quarter worth approximately $28,000. 1248 Management LLC acquired a new stake in Cigna Group during the 1st quarter worth approximately $29,000. Activest Wealth Management lifted its holdings in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock worth $30,000 after buying an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC lifted its holdings in Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock worth $33,000 after buying an additional 43 shares in the last quarter. Finally, Saudi Central Bank acquired a new stake in Cigna Group during the 1st quarter worth approximately $36,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.70% of the company's stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $311.24 on Friday. The company's fifty day moving average price is $292.41 and its 200 day moving average price is $309.73. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $83.08 billion, a P/E ratio of 16.99, a P/E/G ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period last year, the firm posted $6.72 EPS. Cigna Group's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is presently 32.97%.

Analysts Set New Price Targets

A number of research firms have issued reports on CI. Wells Fargo & Company reduced their target price on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Barclays increased their target price on shares of Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Friday. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $371.81.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.